|
S.V. Shalaev (1, 2), Z.M. Safiullina (1), N.A. Mikhalchuk (1)
STATINS AND THE RISK FOR NEW-ONSET DIABETES: RISK-BENEFIT RATIO. MODERN VIWES ON TARGET LIPID LEVELS IN DIABETES PATIENTS
|
№16 / 2014
|
|
S.V. Shalaev (1), Z.M. Safiullina (2), AA Kozlov (2)
STATINS AND ACUTE CORONARY SYNDROME: FEASIBILITY, ADVISABILITY, AND MANAGEMENT OF PATIENTS
|
№18 / 2013
|
|
V.N. Shishkova
Clinical Correlation Of Osteoporosis And Atherosclerosis
|
№s1-12 / 2012
|
|
L.A. Zvenigorodskaya
Lipid-lowering Therapy In Patients With Nonalcoholic Fatty Liver Disease
|
№10 / 2011
|
|
T.Kispaeva
Pathogenetic Aspects Of Statin Use For Preventive And Therapeutic Correction Of Cognitive Impairments Of Vascular Genesis
|
№8 / 2010
|
|
N. Sokolova, I. Yavelov, Y. Belousov, M. Leonova, Y. Maklakova
Moderate Doses Of Statins And Combination Of Statin With Ezetimibe In Patients With Carotide Atherosclerosis: Influence On Blood Lipids, Inflammation Markers And Thickness Of Intima-media Complex
|
№5 / 2010
|
|
E. Vasil'eva, I. Vorobyova С. 1421
Outpatient Management Of Patients After Myocardial Infarction
|
№20 / 2009
|
|
D.A. Zateishikov C. 1014
New Targets Of Treatment Of Patient From The Risk Group For Vascular Complications Of Atherosclerosis
|
№10 / 2009
|
|
L.O. Minushkina
Simvastatin In The Treatment Of Atherosclerosis
|
№8 / 2009
|
|
A.M. Shilov, A. Sh. Avshalumov, V.B. Markovskiy, E.N. Sinitsyna, E.G. Tanaeva, R.U. Baltaeva
Tactics Of Dyslipidemias Treatment In Metabolic Syndrome: Statins Or Fibrates?
|
№6 / 2009
|
Русский
